XML 78 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
 12 Months Ended
Dec. 31, 2014
Valuation and Qualifying Accounts [Abstract]  
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS
 
Balance at Beginning of Period
 
Charged to Costs and Expenses
 
Charged to Other Accounts (1)
 
Deductions
 
Balance at End of Period
Description
 
 
 
 
 
(In thousands)
 
 
Year ended December 31, 2014:
 
 
 
 
 
 
 
 
 
Allowance for doubtful accounts and sales returns and allowances
$
6,194

 
1,944

 
—

 
(1,954
)
 
$
6,184

Deferred tax asset valuation allowance (As adjusted)*
9,060

 
(1,102
)
 
—

 
(698
)
 
7,260

Year ended December 31, 2013:
 
 
 
 
 
 
 
 
 
Allowance for doubtful accounts and sales returns and allowances
$
7,221

 
$
601

 
$
—

 
$
(1,628
)
 
$
6,194

Deferred tax asset valuation allowance (As adjusted)*
14,243

 
(4,469
)
 
—

 
(714
)
 
9,060

Year ended December 31, 2012:
 
 
 
 
 
 
 
 
 
Allowance for doubtful accounts and sales returns and allowances
$
6,978

 
$
1,315

 
$
—

 
$
(1,072
)
 
$
7,221

Deferred tax asset valuation allowance
32,304

 
(16,979
)
 
477

 
(1,559
)
 
14,243

(1) In 2012, $0.5 million of deferred tax liability was reclassified to the valuation allowance with no impact to the consolidated statement of operations. There were no such reclassification adjustments made during 2014 or 2013.
*See Note 2 of these consolidated financial statements for discussion of the impact of the change in accounting for the medical device excise tax.